In a study published in the journal Nature Reviews Drug Discovery last week, a group of Harvard Medical School researchers found that early trials of certain central nervous system drugs weren’t very predictive of whether the drugs ultimately worked. Aaron Kesselheim (Brigham and Women’s) led the research.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?